In vitro and in vivo interactions of .DELTA.8-tetrahydrocannabinol and its metabolites with hepatic microsomal drug metabolizing enzyme systems of mice.
Authors:
- Kazuhito WatanabeKWKazuhito Watanabe
- Ikuo YamamotoIYIkuo Yamamoto
- Kazuta OguriKOKazuta Oguri
- Hidetoshi YoshimuraHYHidetoshi Yoshimura
- 1 January 1981
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Journal of Pharmacobio-Dynamics
- Vol. 4 (8) , 604-611
Abstract
Interactions of delta 8-tetrahydrocannabinol (delta 8-THC) and its metabolites, 11-hydroxy-delta 8-THC, 11-oxo-delta 8-THC and delta 8-THC-11-oic acid, with hepatic microsomal drug metabolizing enzyme were studied in vitro and in vivo using mice. All the cannabinoids used were shown to produce a type I spectral change of cytochrome P-450 in hepatic microsomes. THe apparent binding affinities (Ks) for delta 8-THC, 11-hydroxy-delta 8-THC, 11-oxo-delta 8-THC and delta 8-THC-11-oic acid were 5.2, 169.6, 33.2 and 148.8 microM, respectively. delta 8-THC, 11-oxo-delta 8-THC and delta 8-THC-11-oic acid (100 microM) caused a significant stimulation of NADPH oxidation in vitro with microsomes. In addition, delta 8-THC (20, 40 and 80 microM) markedly inhibited p-nitroanisole O-demethylase and aniline hydroxylase in microsomes. 11-Hydroxy-delta 8-THC and 11-oxo-delta 8-THC also showed the inhibitory effect, but to lesser extents. Furthermore, single pretreatments with delta 8-THC and 11-oxo-delta 8-THC (30 mg/kg, i.v.) significantly decreased activities of p-nitroanisole O-demethylase and aniline hydroxylase in hepatic microsomes, accompanying a decrease of cytochrome P-450 content in case of delta 8-THC. On the other hand, all these pretreatments except for that with delta 8-THC-11-oic acid showed a stimulatory effect on p-nitrophenol glucuronidation with hepatic microsomes, in contrast to an inhibitory effect in vitro.Keywords
This publication has 10 references indexed in Scilit:
- Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.Drug Metabolism and Disposition, 1981
- Comparison in mice of pharmacological effects of Δ8-tetrahydrocannabinol and its metabolites oxidized at 11-positionEuropean Journal of Pharmacology, 1980
- Spectral interaction of 11-hydroxy-.DELTA.8-tetrahydrocannabinol with rabbit and rat liver microsomal cytochrome P-450.Chemical and Pharmaceutical Bulletin, 1980
- Identification and determination of 11-oxo-.DELTA.8-tetrahydrocannabinol as an intermediate metabolite of .DELTA.8-tetrahydrocannabinol in the mouse brain and liver.Journal of Pharmacobio-Dynamics, 1980
- The pharmacokinetic fate of cannabidiol and its relationship to barbiturate sleep timeBiochemical Pharmacology, 1979
- The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristicsBiochemical Pharmacology, 1978
- Control of UDP-glucuronyltransferase activityBiochemical Pharmacology, 1975
- Evidence for Biochemically Different Types of Vesicles in the Hepatic Microsomal Fraction*The Journal of Biochemistry, 1966
- The Carbon Monoxide-binding Pigment of Liver MicrosomesJournal of Biological Chemistry, 1964
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951